A Clinical Trial of Recombinant COVID-19 Bivalent (XBB+Prototype) Protein Vaccine (Sf9 Cell) in Booster Vaccination

NCT05911048 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

3100

Enrollment

INDUSTRY

Sponsor class

Conditions

COVID-19

Interventions

BIOLOGICAL: Recombinant COVID-19 Bivalent (XBB+Prototype) Protein Vaccine (Sf9 Cell) (WSK-V101C)
BIOLOGICAL: Recombinant COVID-19 vaccine(Sf9 Cell) (WSK-V101)

Sponsor

WestVac Biopharma Co., Ltd.